Rapid FOB test

colorectal cancerhemoglobinfor tumor markers

Vitassay FOB 50+200 is a rapid immunochromatigraphic, one step assay for the simultaneous qualitative detection of human hemoglobin in human stool samples. Simple, non-invasive and highly sensitivity immunoassay for the detection of human hemoglobin for the presumptive diagnosis of gastrointestinal bleeding. INTRODUCTION The majority of the colorectal cancers are developed through adenomatous polyps. Although the presence of polyps is frequent in the population, just a little percentage will become cancer. The average time needed to complete this progression is long, probably 10 years or more, and this fact allows early preventing or detecting the colorectal cancer and ameliorating the diagnosis. Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer deaths worldwide. It is one of the main cancers that is preventable with screening. Although colonoscopy is regarded as the most effective screening tool, it can be invasive and labour-intense. Faecal occult blood test (FOBT) is non-invasive and easily performed at home or in clinics; it is more suitable for population-based screening with FOBT has been demonstrated to reduce CRC incidence by 20% and mortality by 33%. Like other cancers, the survival of patients with CRC is closely related to the stage at diagnosis. Early detection of CRC is not only associated with improvements outcomes, but also significantly reduces the cost of treatment. Current screening tests for CRC involve the detection of blood in stool samples and the visualization of gross abnormalities by colonoscopy. Although colonoscopy is still the gold standard method for CRC screening, diagnosis and treatment,